Sage Therapeutics Stock Rockets on Two Positive Phase III Trials in Postpartum Depression Post author:Sam Post published:November 8, 2017 Post category:BioPharma The positive results support the company’s planned regulatory submissions. Source: BioSpace You Might Also Like Interview Insider: Tips on How to Get Hired at Five Prime Therapeutics February 7, 2018 Sanofi: Availability Of The Pre-Quarterly Results Communication July 12, 2017 Achaogen COO Promoted to Top Post, Effective Jan. 1, 2018 December 11, 2017
